Instrument Inactif

Cours LA JOLL Nasdaq

Actions

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

La Jolla : Pharmaceutical Company : Receives Positive Opinion from European Orphan Committee for LJPC-401	11/09/15
La Jolla : Pharmaceutical Company : Announces Pricing of Underwritten Offering of Common Stock	10/09/15
La Jolla : Pharmaceutical Company : Announces Proposed Underwritten Offering of Common Stock	09/09/15
La Jolla : Pharmaceutical Company : Receives Orphan Drug Designation for Two Novel Compounds for Fibrodysplasia Ossificans Progressiva	18/08/15
La Jolla : Pharmaceutical Company : and Vanderbilt University Enter Exclusive Research and License Agreement Covering Novel BMP Type-I Receptor Inhibitors	18/08/15

Secteur